Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells
The implementation of chemo- and bioinformatics tools is a crucial step in the design of structure-based drugs, enabling the identification of more specific and effective molecules against cancer without side effects. In this study, three new compounds were designed and synthesized with suitable abs...
Saved in:
Main Authors: | David Méndez-Luna (Author), Loreley Araceli Morelos-Garnica (Author), Juan Benjamín García-Vázquez (Author), Martiniano Bello (Author), Itzia Irene Padilla-Martínez (Author), Manuel Jonathan Fragoso-Vázquez (Author), Alfonso Dueñas González (Author), Nuria De Pedro (Author), José Antonio Gómez-Vidal (Author), Humberto Lubriel Mendoza-Figueroa (Author), José Correa-Basurto (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist
by: Qingming Ding, et al.
Published: (2022) -
Commentary: harnessing the first peptidic modulator of the estrogen receptor GPER
by: Rosamaria Lappano, et al.
Published: (2024) -
Inhibition of PI3K/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells
by: Danning Shi, et al.
Published: (2020) -
Identification of the estrogen receptor GPER in neoplastic and non-neoplastic human testes
by: Maggiolini Marcello, et al.
Published: (2011) -
Repurposing FDA Drug Compounds against Breast Cancer by Targeting EGFR/HER2
by: Irving Balbuena-Rebolledo, et al.
Published: (2021)